Literature DB >> 18368538

Cardiac expression of Brn-3a and Brn-3b POU transcription factors and regulation of Hsp27 gene expression.

Saleha R Farooqui-Kabir1, James K J Diss, Deborah Henderson, Michael S Marber, David S Latchman, Vishwanie Budhram-Mahadeo, Richard J Heads.   

Abstract

The Brn-3 family of transcription factors play a critical role in regulating expression of genes that control cell fate, including the small heat shock protein Hsp27. The aim of this study was to investigate the relationship between Brn-3a and Brn-3b and Hsp27 expression in the developing rodent heart. Brn-3a and Brn-3b were detected from embryonic days 9.5-10.5 (E9.5-E10.5) in the mouse heart, with significant increases seen later during development. Two isoforms (long and short) of each protein were detected during embryogenesis and postnatally. Brn-3a messenger RNA (mRNA) and protein were localized by E13.0 to the atrio-ventricular (AV) valve cushions and leaflets, outflow tract (OFT), epicardium and cardiac ganglia. By E14.5, Brn-3a was also localised to the septa and compact ventricular myocardium. An increase in expression of the long Brn-3a(l) isoform between E17 and adult coincided with a decrease in expression of Brn-3b(l) and a marked increase in expression of Hsp27. Hearts from Brn-3a-/- mice displayed a partially penetrant phenotype marked by thickening of the endocardial cushions and AV valve leaflets and hypoplastic ventricular myocardium. Loss of Brn-3a was correlated with a compensatory increase in Brn-3b and GATA3 mRNA but no change in Hsp27 mRNA. Reporter assays in isolated cardiomyocytes demonstrated that both Brn-3a and Brn-3b activate the hsp27 promoter via a consensus Brn-3-binding site. Therefore, Brn-3 POU factors may play an important role in the development and maintenance of critical cell types and structures within the heart, in part via developmental regulation of myocardial Hsp27 expression. Furthermore, Brn-3a may be necessary for correct valve and myocardial remodelling and maturation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368538      PMCID: PMC2673938          DOI: 10.1007/s12192-008-0028-2

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  40 in total

1.  A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells.

Authors:  K A Lillycrop; V S Budrahan; N D Lakin; G Terrenghi; J N Wood; J M Polak; D S Latchman
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

Review 2.  HSP gene expression and HSF2 in mouse development.

Authors:  M T Loones; M Rallu; V Mezger; M Morange
Journal:  Cell Mol Life Sci       Date:  1997-02       Impact factor: 9.261

3.  Targeted deletion of the mouse POU domain gene Brn-3a causes selective loss of neurons in the brainstem and trigeminal ganglion, uncoordinated limb movement, and impaired suckling.

Authors:  M Xiang; L Gan; L Zhou; W H Klein; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  The levels of the antagonistic POU family transcription factors Brn-3a and Brn-3b in neuronal cells are regulated in opposite directions by serum growth factors.

Authors:  V Budhram-Mahadeo; K A Lillycrop; D S Latchman
Journal:  Neurosci Lett       Date:  1995-02-06       Impact factor: 3.046

5.  Short isoform of POU factor Brn-3b can form a heterodimer with Brn-3a that is inactive for octamer motif binding.

Authors:  T Theil; B Rödel; F Spiegelhalter; T Möröy
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

6.  Activation of the alpha-internexin promoter by the Brn-3a transcription factor is dependent on the N-terminal region of the protein.

Authors:  V Budhram-Mahadeo; P J Morris; N D Lakin; T Theil; G Y Ching; K A Lillycrop; T Möröy; R K Liem; D S Latchman
Journal:  J Biol Chem       Date:  1995-02-10       Impact factor: 5.157

7.  Brn-3.2: a Brn-3-related transcription factor with distinctive central nervous system expression and regulation by retinoic acid.

Authors:  E E Turner; K J Jenne; M G Rosenfeld
Journal:  Neuron       Date:  1994-01       Impact factor: 17.173

8.  POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells.

Authors:  L Gan; M Xiang; L Zhou; D S Wagner; W H Klein; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

9.  The Brn-3 family of POU-domain factors: primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons.

Authors:  M Xiang; L Zhou; J P Macke; T Yoshioka; S H Hendry; R L Eddy; T B Shows; J Nathans
Journal:  J Neurosci       Date:  1995-07       Impact factor: 6.167

10.  Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate.

Authors:  Chantelle D Hudson; Peter J Morris; David S Latchman; Vishwanie S Budhram-Mahadeo
Journal:  J Biol Chem       Date:  2004-12-13       Impact factor: 5.157

View more
  5 in total

1.  Brn3a regulates the transition from neurogenesis to terminal differentiation and represses non-neural gene expression in the trigeminal ganglion.

Authors:  Jason Lanier; Iain M Dykes; Stephanie Nissen; S Raisa Eng; Eric E Turner
Journal:  Dev Dyn       Date:  2009-12       Impact factor: 3.780

2.  Co-expression of POU4F2/Brn-3b with p53 may be important for controlling expression of pro-apoptotic genes in cardiomyocytes following ischaemic/hypoxic insults.

Authors:  V Budhram-Mahadeo; R Fujita; S Bitsi; P Sicard; R Heads
Journal:  Cell Death Dis       Date:  2014-10-30       Impact factor: 8.469

3.  Essential but partially redundant roles for POU4F1/Brn-3a and POU4F2/Brn-3b transcription factors in the developing heart.

Authors:  Lauren J Maskell; Kashif Qamar; Aram A Babakr; Thomas A Hawkins; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Cell Death Dis       Date:  2017-06-08       Impact factor: 8.469

4.  The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart.

Authors:  Laura Mele; Lauren J Maskell; Daniel J Stuckey; James E Clark; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Cell Death Dis       Date:  2019-08-14       Impact factor: 8.469

Review 5.  Linking metabolic dysfunction with cardiovascular diseases: Brn-3b/POU4F2 transcription factor in cardiometabolic tissues in health and disease.

Authors:  Vishwanie S Budhram-Mahadeo; Matthew R Solomons; Eeshan A O Mahadeo-Heads
Journal:  Cell Death Dis       Date:  2021-03-12       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.